Related Experiment Video
Updated: Aug 15, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
piRNA and miRNA Can Suppress the Expression of Multiple Sclerosis Candidate Genes
Saltanat Kamenova1, Aksholpan Sharapkhanova2, Aigul Akimniyazova1
1Higher School of Medicine, Faculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Abstract:
Multiple sclerosis (MS) is a common inflammatory demyelinating disease with a high mortality rate. MS is caused by many candidate genes whose specific involvement has yet to be established. The aim of our study was to identify endogenous miRNAs and piRNAs involved in the regulation of MS candidate gene expression using bioinformatic methods. A program was used to quantify the interaction of miRNA and piRNA nucleotides with mRNA of the target genes. We used 7310 miRNAs from three databases and 40,000 piRNAs. The mRNAs of the candidate genes revealed miRNA binding sites (BSs), which were located separately or formed clusters of BSs with overlapping nucleotide sequences. The miRNAs from the studied databases were generally bound to mRNAs in different combinations, but miRNAs from only one database were bound to the mRNAs of some genes. For the first time, a direct interaction between the complete sequence of piRNA nucleotides and the nucleotides of their mRNA BSs of target genes was shown. One to several clusters of BSs of miRNA and piRNA were identified in the mRNA of ADAM17, AHI1, CD226, EOMES, EVI5, IL12B, IL2RA, KIF21B, MGAT5, MLANA, SOX8, TNFRSF1A, and ZBTB46 MS candidate genes. These piRNAs form the expression regulation system of the MS candidate genes to coordinate the synthesis of their proteins. Based on these findings, associations of miRNAs, piRNAs, and candidate genes for MS diagnosis are recommended.
Insights
This study identifies microRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs) regulating multiple sclerosis (MS) candidate genes. These small RNAs directly interact with gene mRNAs, offering potential biomarkers for MS diagnosis and treatment.
Area of Science:
- Genetics
- Immunology
- Bioinformatics
Background:
- Multiple sclerosis (MS) is an inflammatory demyelinating disease with significant mortality.
- The genetic underpinnings of MS are complex and not fully elucidated.
- Understanding gene regulation in MS is crucial for developing effective therapies.
Purpose of the Study:
- To identify endogenous microRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs) involved in regulating MS candidate gene expression.
- To investigate the direct interactions between miRNAs, piRNAs, and their target messenger RNAs (mRNAs).
Main Methods:
- Bioinformatic analysis was employed to identify regulatory RNAs.
- A program quantified interactions between miRNA/piRNA nucleotides and mRNA binding sites (BSs).
- Data from 7310 miRNAs and 40,000 piRNAs across multiple databases were analyzed.
Main Results:
- miRNA binding sites were identified on MS candidate gene mRNAs, some forming clusters.
- A direct interaction between complete piRNA sequences and their mRNA BSs was demonstrated for the first time.
- Clusters of miRNA and piRNA binding sites were found in 13 key MS candidate genes (e.g., ADAM17, IL12B, TNFRSF1A).
Conclusions:
- piRNAs form an expression regulation system for MS candidate genes, coordinating protein synthesis.
- The identified miRNAs and piRNAs show potential as biomarkers for MS diagnosis.
- Further research into these RNA associations could lead to novel therapeutic strategies for MS.
Related Concept Videos
MicroRNAs
piRNA - Piwi-interacting RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Small interfering RNAs (siRNA)

